AI tool to help fight respiratory conditions

"Global pharma firm Chiesi and French AI startup Hephaï have joined forces to develop a digital solution to support improved inhaler use.
The platform is designed for patients with asthma and chronic obstructive pulmonary disease (COPD). It aims to help them better control their condition.
The app will be available on Apple and Android in 2022.
Both asthma and COPD are frequently treated with medication taken via inhalers; patients have to make regular use of inhalers in order to take their medication correctly.
Errors in inhaler use may occur if the patient struggles to use it, or if they are not yet accustomed to it.
Research shows that 30-40 per cent of patients with COPD do not use their inhalers correctly.
This can have a direct impact on how they take the medication, reducing its benefits.
Specialist pulmonologists and GPs do not always have the time to monitor inhaler use in patients or offer full instructions on comprehensive use.
Also, patients are not always given thorough guidance when they collect their inhaler from a pharmacy.
As a result, many are unaware of the correct techniques to use their inhaler effectively, as they lack professional training or advice, or they may simply forget what they have been told..." Lire la suite